Shares of Roka Bioscience, Inc. (NASDAQ:ROKA) rose 17.9% on Tuesday . The company traded as high as $1.27 and last traded at $0.99. Approximately 571,742 shares traded hands during mid-day trading, an increase of 667% from the average daily volume of 74,586 shares. The stock had previously closed at $1.21.

The firm’s 50 day moving average price is $1.62 and its 200 day moving average price is $2.79. The company’s market capitalization is $4.81 million.

In related news, major shareholder Orbimed Advisors Llc sold 75,276 shares of the company’s stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $1.52, for a total transaction of $114,419.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Over the last quarter, insiders have sold 90,676 shares of company stock valued at $137,520. 29.10% of the stock is owned by corporate insiders.

A hedge fund recently bought a new stake in Roka Bioscience stock. AWM Investment Company Inc. acquired a new position in shares of Roka Bioscience, Inc. (NASDAQ:ROKA) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 132,297 shares of the medical research company’s stock, valued at approximately $352,000. AWM Investment Company Inc. owned approximately 2.64% of Roka Bioscience at the end of the most recent reporting period. 66.51% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Roka Bioscience, Inc. (ROKA) Stock Price Up -17.9%” was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright & trademark law. The original version of this piece of content can be read at

About Roka Bioscience

Roka Bioscience, Inc is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.

Receive News & Ratings for Roka Bioscience Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roka Bioscience Inc. and related companies with's FREE daily email newsletter.